Literature DB >> 19959938

Hepatocyte growth factor enhances ovarian cancer cell invasion through downregulation of thrombospondin-1.

Wei Wei1, Beihua Kong, Qifeng Yang, Xun Qu.   

Abstract

Hepatocyte growth factor (HGF) plays an important role in stimulating tumor invasion and metastasis of tumor cells. However, the exact mechanisms of HGF regulation of cell invasion are largely unknown. In this study, we demonstrated that the MAPK specific inhibitor U0126 prevented the HGF-induced invasion of SKOV-3 cells. HGF stimulation of cell invasion and enhancement of MMP-9 expression were partially suppressed by TSP-1 overexpression. Furthermore, the MAPK signaling pathway is predominantly responsible for HGF-induced TSP-1 downregulation. We conclude that HGF is a potential downregulator of TSP-1, through MAPK signaling pathways, leading to the induction of MMP-9 expression and subsequent invasion of SKOV-3 cells. This study enhances our understanding of the mechanisms of signaling transduction in the HGF-induced invasion and progression of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19959938     DOI: 10.4161/cbt.9.2.10280

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  11 in total

1.  Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway.

Authors:  Zhe Lu; Lei Ding; Heng Hong; John Hoggard; Qun Lu; Yan-Hua Chen
Journal:  Exp Cell Res       Date:  2011-05-27       Impact factor: 3.905

2.  Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.

Authors:  Wenbin Kuang; Qiuchan Deng; Chuntao Deng; Wensheng Li; Shaowei Shu; Meirong Zhou
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 3.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

Review 4.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

5.  Thrombospondin-1 and VEGF in inflammatory bowel disease.

Authors:  Canan Alkim; Damlanur Sakiz; Huseyin Alkim; Ayten Livaoglu; Tulin Kendir; Huseyin Demirsoy; Levent Erdem; Nihat Akbayir; Mehmet Sokmen
Journal:  Libyan J Med       Date:  2012-01-30       Impact factor: 1.657

6.  Single-cell Migration Chip for Chemotaxis-based Microfluidic Selection of Heterogeneous Cell Populations.

Authors:  Yu-Chih Chen; Steven G Allen; Patrick N Ingram; Ronald Buckanovich; Sofia D Merajver; Euisik Yoon
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

7.  Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.

Authors:  Agnieszka Horala; Agata Swiatly; Jan Matysiak; Paulina Banach; Ewa Nowak-Markwitz; Zenon J Kokot
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

8.  Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.

Authors:  Martyna Pakuła; Anna Witucka; Paweł Uruski; Artur Radziemski; Rafał Moszyński; Dariusz Szpurek; Konstantin Maksin; Aldona Woźniak; Stefan Sajdak; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

9.  Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.

Authors:  Yasuyoshi Miyata; Shin-ichi Watanabe; Hiroshi Kanetake; Hideki Sakai
Journal:  BMC Cancer       Date:  2012-08-28       Impact factor: 4.430

10.  TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.

Authors:  Xiao Yang; Pengchao Li; Xuejian Yang; Chao Qin; Qiang Cao; Zhengdong Zhang; Meilin Wang; Hongzhou Cai; Jinbao Gu; Jun Tao; Min Gu; Qiang Lu; Changjun Yin
Journal:  Int J Genomics       Date:  2013-12-03       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.